Idexx Laboratories, Inc’s filing revealed that its Executive Vice President FENNELL GEORGE unloaded Company’s shares for reported $4.62 million on Feb 10 ’25. In the deal valued at $462.53 per share,9,986 shares were sold. As a result of this transaction, FENNELL GEORGE now holds 8,176 shares worth roughly $3.79 million.
Then, FENNELL GEORGE bought 9,966 shares, generating $4,618,863 in total proceeds.
Before that, SZOSTAK M ANNE sold 3,000 shares. Idexx Laboratories, Inc shares valued at $1,397,835 were divested by the Director at a price of $465.94 per share. As a result of the transaction, SZOSTAK M ANNE now holds 3,061 shares, worth roughly $1.42 million.
Leerink Partners initiated its Idexx Laboratories, Inc [IDXX] rating to an Outperform in a research note published on December 02, 2024; the price target was $500. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Piper Sandler also remained covering IDXX and has decreased its forecast on January 30, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Exane BNP Paribas started covering the stock on December 07, 2023. It rated IDXX as “an Outperform”.
Price Performance Review of IDXX
On Tuesday, Idexx Laboratories, Inc [NASDAQ:IDXX] saw its stock fall -0.25% to $463.74. Over the last five days, the stock has lost -0.28%. Idexx Laboratories, Inc shares have risen nearly 12.17% since the year began. Nevertheless, the stocks have fallen -19.15% over the past one year. While a 52-week high of $583.39 was reached on 02/03/25, a 52-week low of $398.50 was recorded on 01/29/25. SMA at 50 days reached $430.22, while 200 days put it at $467.43.
Levels Of Support And Resistance For IDXX Stock
The 24-hour chart illustrates a support level at 460.12, which if violated will result in even more drops to 456.49. On the upside, there is a resistance level at 467.53. A further resistance level may holdings at 471.31. The Relative Strength Index (RSI) on the 14-day chart is 63.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 17.85, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 15.87%. Stochastics %K at 82.78% indicates the stock is a selling.
How much short interest is there in Idexx Laboratories, Inc?
A steep rise in short interest was recorded in Idexx Laboratories, Inc stocks on 2025-01-15, growing by 0.33 million shares to a total of 1.73 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 1.4 million shares. There was a rise of 19.15%, which implies that there is a positive sentiment for the stock.
